Overview

A class action lawsuit has been filed against Edward Lifesciences Corporation (“Edwards” or the “Company”) (NYSE: EW) and certain of the Company’s former and current senior executive officers alleging violations of the federal securities laws.  The Edwards class action lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February 6, 2024, to July 24, 2024, both dates inclusive (the “Class Period”).  Investors have until December 13, 2024, to seek appointment as lead plaintiff in the Edwards class action lawsuit.

Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies as well as critical care monitoring solutions.  Edwards categorizes its therapies and technologies into four categories: Transcatheter Aortic Valve Replacement (“TAVR”), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart therapies, and Critical Care therapies.

The Edwards class action lawsuit claims that the Defendants misled investors about the Company’s projected 2024 revenue, specifically regarding the growth of its TAVR product.  Defendants expressed strong confidence in the TAVR platform, citing significant demand in underpenetrated markets and the potential to engage untreated patients through various activation activities.  However, while making these optimistic statements, they allegedly concealed or misrepresented key facts, including their overestimation of both the ability to engage untreated patients and the willingness of hospitals to continue supporting TAVR procedures over newer treatment options.

*          *          *

If you purchased or otherwise acquired Edwards securities between February 6, 2024, to July 24, 2024, both dates inclusive and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as a lead plaintiff in the Edwards class action lawsuit is December 13, 2024.